---
title: "ICU Medical, Inc. (ICUI.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ICUI.US.md"
symbol: "ICUI.US"
name: "ICU Medical, Inc."
industry: "Health Care Supplies"
datetime: "2026-05-20T22:33:47.183Z"
locales:
  - [en](https://longbridge.com/en/quote/ICUI.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ICUI.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ICUI.US.md)
---

# ICU Medical, Inc. (ICUI.US)

## Company Overview

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services.

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Exchange | US Market |
| Website | [www.icumed.com](https://www.icumed.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:15.000Z

**Overall: C (0.51)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 16 / 45 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -10.88% |  |
| Net Profit YoY | 149.46% |  |
| P/B Ratio | 1.46 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 3090706721.10 |  |
| Revenue | 2156785000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 2.26% | C |
| Profit Margin | 2.15% | C |
| Gross Margin | 38.89% | B |
| Revenue YoY | -10.88% | E |
| Net Profit YoY | 149.46% | A |
| Total Assets YoY | -4.08% | D |
| Net Assets YoY | 6.25% | B |
| Cash Flow Margin | 361.31% | A |
| OCF YoY | -10.88% | E |
| Turnover | 0.53 | C |
| Gearing Ratio | 47.38% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - ICU Medical, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-10.88%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "149.46%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.46",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "3090706721.10",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "2156785000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "2.26%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "2.15%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "38.89%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "-10.88%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "149.46%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "-4.08%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "6.25%",
          "rating": "B"
        },
        {
          "name": "Cash Flow Margin",
          "value": "361.31%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "-10.88%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "0.53",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "47.38%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 66.70 | 19/45 | 4485.66 | 4291.04 | 4069.80 |
| PB | 1.46 | 20/45 | 1.71 | 1.57 | 1.45 |
| PS (TTM) | 1.43 | 13/45 | 1.56 | 1.38 | 1.30 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Essilor (ESLOY.US) | B | B | C | B | B | B |
| 02 | HOYA Corporation (HOCPY.US) | A | C | B | A | B | B |
| 03 | Align (ALGN.US) | B | C | B | B | C | B |
| 04 | Lantheus (LNTH.US) | A | C | B | C | C | B |
| 05 | Merit Medical (MMSI.US) | B | B | B | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-11T04:00:00.000Z

Total Analysts: **7**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 3 | 43% |
| Overweight | 3 | 43% |
| Hold | 1 | 14% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 129.31 |
| Highest Target | 200.00 |
| Lowest Target | 163.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/ICUI.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/ICUI.US/norm.md)
- [Related News](https://longbridge.com/en/quote/ICUI.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/ICUI.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**